Graham Capital Management’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $342K | Buy |
+302,270
| New | +$342K | 0.01% | 909 |
|
|
2025
Q1 | – | Sell |
-41,737
| Closed | -$88.9K | – | 1233 |
|
|
2024
Q4 | $88.9K | Buy |
+41,737
| New | +$88.9K | ﹤0.01% | 1140 |
|
|
2023
Q3 | – | Sell |
-62,431
| Closed | -$310K | – | 982 |
|
|
2023
Q2 | $310K | Buy |
62,431
+41,525
| +199% | +$206K | 0.01% | 661 |
|
|
2023
Q1 | $103K | Buy |
+20,906
| New | +$103K | ﹤0.01% | 990 |
|
|
2022
Q4 | – | Sell |
-103,895
| Closed | -$1.12M | – | 1020 |
|
|
2022
Q3 | $1.12M | Sell |
103,895
-130,975
| -56% | -$1.41M | 0.04% | 427 |
|
|
2022
Q2 | $2.68M | Buy |
234,870
+91,040
| +63% | +$1.04M | 0.11% | 127 |
|
|
2022
Q1 | $1.31M | Buy |
+143,830
| New | +$1.31M | 0.05% | 209 |
|